Biopharmaceutical company Silo Pharma launches cryptocurrency fund management strategy
ChainCatcher news, biopharmaceutical company Silo Pharma (NASDAQ: SILO) today announced the launch of a cryptocurrency fund management strategy and appointed cryptocurrency infrastructure expert Corwin Yu as the first member of its cryptocurrency advisory board. The strategy will focus on mainstream digital assets such as Bitcoin, Ethereum, and SOL.
ChainCatcher reminds readers to view blockchain rationally, enhance risk awareness, and be cautious of various virtual token issuances and speculations. All content on this site is solely market information or related party opinions, and does not constitute any form of investment advice. If you find sensitive information in the content, please click , and we will handle it promptly.
Related tags






